Cardiovalve Ltd.
Clinical trials sponsored by Cardiovalve Ltd., explained in plain language.
-
New heart valve implant offers hope for patients too sick for surgery
Disease control Recruiting nowThis study is testing a new device called the Cardiovalve system to treat severe tricuspid regurgitation, a serious heart valve leak. The device is delivered through a vein in the leg to replace the leaky valve without open-heart surgery. Researchers aim to show the device is saf…
Phase: NA • Sponsor: Cardiovalve Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New heart valve implant trial offers hope for patients with severe leakage
Disease control Recruiting nowThis study is testing a new device called the Cardiovalve TR system, which is designed to replace a leaky heart valve (tricuspid valve). It will involve about 100 patients who have severe leakage and symptoms like shortness of breath. The main goals are to see if the procedure is…
Phase: NA • Sponsor: Cardiovalve Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC